These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30533017)

  • 1. Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs.
    Kuraoka M; Nitahara-Kasahara Y; Tachimori H; Kato N; Shibasaki H; Shin A; Aoki Y; Kimura E; Takeda S
    PLoS One; 2018; 13(12):e0208415. PubMed ID: 30533017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan.
    Kuraoka M; Aoki Y; Takeda S
    Exp Anim; 2021 Nov; 70(4):419-430. PubMed ID: 34135266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.
    Gaiad TP; Araujo KP; Serrão JC; Miglino MA; Ambrósio CE
    PLoS One; 2014; 9(4):e93500. PubMed ID: 24713872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring.
    Shin JH; Greer B; Hakim CH; Zhou Z; Chung YC; Duan Y; He Z; Duan D
    PLoS One; 2013; 8(3):e59875. PubMed ID: 23544107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.
    Shimatsu Y; Yoshimura M; Yuasa K; Urasawa N; Tomohiro M; Nakura M; Tanigawa M; Nakamura A; Takeda S
    Acta Myol; 2005 Oct; 24(2):145-54. PubMed ID: 16550932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy.
    Kuraoka M; Kimura E; Nagata T; Okada T; Aoki Y; Tachimori H; Yonemoto N; Imamura M; Takeda S
    Am J Pathol; 2016 May; 186(5):1302-12. PubMed ID: 26963343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.
    Echigoya Y; Nakamura A; Nagata T; Urasawa N; Lim KRQ; Trieu N; Panesar D; Kuraoka M; Moulton HM; Saito T; Aoki Y; Iversen P; Sazani P; Kole R; Maruyama R; Partridge T; Takeda S; Yokota T
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4213-4218. PubMed ID: 28373570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.
    Fraysse B; Barthélémy I; Qannari EM; Rouger K; Thorin C; Blot S; Le Guiner C; Chérel Y; Hogrel JY
    BMC Musculoskelet Disord; 2017 Apr; 18(1):153. PubMed ID: 28403854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy.
    Gaiad TP; Silva MB; Silva GC; Caromano FA; Miglino MA; Ambrósio CE
    Res Vet Sci; 2011 Oct; 91(2):188-93. PubMed ID: 21315399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasome in animal models of Duchenne muscular dystrophy.
    Chen CN; Graber TG; Bratten WM; Ferrington DA; Thompson LV
    J Muscle Res Cell Motil; 2014 Apr; 35(2):191-201. PubMed ID: 24934129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Gerhalter T; Gast LV; Marty B; Martin J; Trollmann R; Schüssler S; Roemer F; Laun FB; Uder M; Schröder R; Carlier PG; Nagel AM
    J Magn Reson Imaging; 2019 Oct; 50(4):1103-1113. PubMed ID: 30719784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.